{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:33:08Z","timestamp":1765233188303,"version":"build-2065373602"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006485","name":"National Institute for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112353","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:31:24Z","timestamp":1634895084000},"page":"112353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A comprehensive review on efficient approaches for combating coronaviruses"],"prefix":"10.1016","volume":"144","author":[{"given":"Mahdi","family":"Pouresmaieli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ekrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Noorbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin Borzooee","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matin","family":"Mamoudifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12575-020-00129-1","article-title":"Potential drugs and remedies for the treatment of COVID-19: a critical review","volume":"22","author":"Barati","year":"2020","journal-title":"Biol. Proced. Online"},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12575-020-00134-4","article-title":"Potential diagnostic systems for coronavirus detection: a critical review","volume":"22","author":"Ekrami","year":"2020","journal-title":"Biol. Proced. Online"},{"year":"2020","author":"Richman","series-title":"Clinical Virology","key":"10.1016\/j.biopha.2021.112353_bib3"},{"issue":"6","key":"10.1016\/j.biopha.2021.112353_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s13312-020-1852-4","article-title":"Perinatal-neonatal management of COVID-19 infection\u2014guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP)","volume":"57","author":"Chawla","year":"2020","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.biopha.2021.112353_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv. Virus Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/joim.13091","article-title":"COVID\u201019 diagnosis and management: a comprehensive review","volume":"288","author":"Pascarella","year":"2020","journal-title":"J. Intern. Med."},{"issue":"01","key":"10.1016\/j.biopha.2021.112353_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3855\/jidc.13384","article-title":"Facing COVID-19 pandemic: development of custom-made face mask with rapid prototyping system","volume":"15","author":"Piombino","year":"2021","journal-title":"J. Infect. Dev. Ctries."},{"unstructured":"John Hopkins University and Medicine \u2013 Coronavirus Resource Center, 2020 COVID-19 case tracker. [cited 2020 10th September].\u00a0\u3008https:\/\/coronavirus.jhu.edu\/map.html\u3009.","key":"10.1016\/j.biopha.2021.112353_bib8"},{"unstructured":"Worldometers, 2021 [cited 2021 9th March]. \u3008https:\/\/www.worldometers.info\/coronavirus\/\u3009.","key":"10.1016\/j.biopha.2021.112353_bib9"},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jmv.26326","article-title":"Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta\u2010analysis","volume":"93","author":"He","year":"2021","journal-title":"J. Med. Virol."},{"unstructured":"nytimes news. [cited 2021 9th March]. \u3008https:\/\/www.nytimes.com\/news-event\/coronavirus\u3009.","key":"10.1016\/j.biopha.2021.112353_bib11"},{"unstructured":"WHO. [cited 2021 9th March]. \u3008https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/question-and-answers-hub\/q-a-detail\/coronavirus-disease-COVID-19#:~:text=symptoms\u3009.","key":"10.1016\/j.biopha.2021.112353_bib12"},{"unstructured":"worldometers. [cited 2021 13th March]. \u3008https:\/\/www.worldometers.info\/coronavirus\/\u3009.","key":"10.1016\/j.biopha.2021.112353_bib13"},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143380","article-title":"Recent endemic coronavirus infection is associated with less-severe COVID-19","volume":"131","author":"Sagar","year":"2021","journal-title":"J. Clin. Investig."},{"unstructured":"WHO. 2021. \u3008www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\u3009.","key":"10.1016\/j.biopha.2021.112353_bib15"},{"unstructured":"nytimes news. 2021 [cited 2020 10th March]. \u3008https:\/\/www.nytimes.com\/interactive\/2021\/health\/coronavirus-variant-tracker.html\u3009.","key":"10.1016\/j.biopha.2021.112353_bib16"},{"unstructured":"Nature. 2021 [cited 2021 10th March]. \u3008https:\/\/www.nature.com\/articles\/d41586\u2013020-00502-w\u3009.","key":"10.1016\/j.biopha.2021.112353_bib17"},{"unstructured":"fortune.com. 2021 [cited 2022 10th March]. \u3008https:\/\/fortune.com\/2021\/01\/22\/uk-virus-strain-more-lethal\/\u3009.","key":"10.1016\/j.biopha.2021.112353_bib18"},{"unstructured":"scientificamerican.com. 2021 [cited 2021 10th March]. \u3008https:\/\/www.scientificamerican.com\/article\/the-most-worrying-mutations-in-five-emerging-coronavirus-variants\/\u3009.","key":"10.1016\/j.biopha.2021.112353_bib19"},{"unstructured":"hopkinsmedicine. 2021 [cited 2021 10th March]. \u3008https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/coronavirus\/a-new-strain-of-coronavirus-what-you-should-know\u3009.","key":"10.1016\/j.biopha.2021.112353_bib20"},{"unstructured":"2021 [cited 2021 30th April]. \u3008https:\/\/www.ema.europa.eu\/en\/news\/astrazenecas-COVID-19-vaccine-benefits-risks-context\u3009.","key":"10.1016\/j.biopha.2021.112353_bib21"},{"unstructured":"nytimes. 2021. \u3008https:\/\/www.nytimes.com\/interactive\/2021\/health\/coronavirus-variant-tracker.html#Q677\u3009.","key":"10.1016\/j.biopha.2021.112353_bib22"},{"unstructured":"WHO. 2021 [cited 2021 3rd October]. \u3008www.who.int\u3009.","key":"10.1016\/j.biopha.2021.112353_bib23"},{"unstructured":"Masks-FaceCoverings. 2021 [cited 2021 20th March]. \u3008https:\/\/easa.com\/Portals\/0\/Images\/COVID19\/Masks-FaceCoverings_Know-the-Difference_USArmy\u3009.","key":"10.1016\/j.biopha.2021.112353_bib24"},{"unstructured":"World Health Organization, Coronavirus disease (COVID-19) advice for the public 2022, 2021 [cited 2021 20th March]. \u3008https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public\u3009.","key":"10.1016\/j.biopha.2021.112353_bib25"},{"unstructured":"WHO. 2021 [cited 2021 14th March]. \u3008https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/who_risk-management_visiting-care-facility.pdf?sfvrsn=1dffe1e6_7\u3009.","key":"10.1016\/j.biopha.2021.112353_bib26"},{"unstructured":"who.int 2021 [cited 2021 20th March]. \u3008https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/question-and-answers-hub\/q-a-detail\/coronavirus-disease-COVID-19-food-safety-for-consumers%20march%208th%20202\u3009.","key":"10.1016\/j.biopha.2021.112353_bib27"},{"key":"10.1016\/j.biopha.2021.112353_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110436","article-title":"International Committee of the Red Cross (ICRC): cemetery planning, preparation and management during COVID-19: a quick guide to proper documentation and disposition of the dead","volume":"316","author":"Finegan","year":"2020","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/CMR.00002-06","article-title":"Role of cell culture for virus detection in the age of technology","volume":"20","author":"Leland","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10156-009-0669-9","article-title":"Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases","volume":"15","author":"Mori","year":"2009","journal-title":"J. Infect. Chemother."},{"issue":"7","key":"10.1016\/j.biopha.2021.112353_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040204","article-title":"DNA detection using recombination proteins","volume":"4","author":"Piepenburg","year":"2006","journal-title":"PLoS Biol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112353_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.embor.7400200","article-title":"Helicase\u2010dependent isothermal DNA amplification","volume":"5","author":"Vincent","year":"2004","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.biopha.2021.112353_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00705-010-0869-8","article-title":"Deep sequencing evidence from single grapevine plants reveals a virome dominated by mycoviruses","volume":"156","author":"Al Rwahnih","year":"2011","journal-title":"Arch. Virol."},{"key":"10.1016\/j.biopha.2021.112353_bib34","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.3389\/fmicb.2018.03255","article-title":"Electron microscopy methods for virus diagnosis and high resolution analysis of viruses","volume":"9","author":"Richert-P\u00f6ggeler","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2021.112353_bib35","series-title":"Diagnostic Procedures for Viral and Rickettsial Infections","first-page":"81","article-title":"Tissue culture technics for diagnostic virology","author":"Schmidt","year":"1969"},{"key":"10.1016\/j.biopha.2021.112353_bib36","series-title":"Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices","first-page":"249","article-title":"Micro-and nanotechnology-based implantable devices and bionics","author":"Bisht","year":"2017"},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib37","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1148\/radiol.2020201160","article-title":"Frequency and distribution of chest radiographic findings in patients positive for COVID-19","volume":"296","author":"Wong","year":"2020","journal-title":"Radiology"},{"issue":"10223","key":"10.1016\/j.biopha.2021.112353_bib38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"unstructured":"Committee, G.O.o.N.H., Office of state administration of traditional Chinese medicine. Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial version 6) [text in Chinese], 2020.","key":"10.1016\/j.biopha.2021.112353_bib39"},{"key":"10.1016\/j.biopha.2021.112353_bib40","first-page":"1","article-title":"Current methods for diagnosis of human coronaviruses: pros and cons","author":"Benzigar","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jviromet.2011.04.024","article-title":"Development of loop-mediated isothermal amplification assay for detection of human coronavirus-NL63","volume":"175","author":"Pyrc","year":"2011","journal-title":"J. Virol. Methods"},{"unstructured":"WHO. 2021 [cited 2021 25th March]. \u3008https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/question-and-answers-hub\/q-a-detail\/coronavirus-disease-COVID-19\u3009.","key":"10.1016\/j.biopha.2021.112353_bib42"},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-019-3345-5","article-title":"An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes","volume":"186","author":"Layqah","year":"2019","journal-title":"Microchim. Acta"},{"issue":"11","key":"10.1016\/j.biopha.2021.112353_bib44","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/elan.201300342","article-title":"Interaction between DNA and some salicylic acid derivatives and characterization of their DNA targets","volume":"25","author":"Abedi","year":"2013","journal-title":"Electroanalysis"},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jinf.2019.09.010","article-title":"Nanotechnology: a reality for diagnosis of HCV infectious disease","volume":"80","author":"Arca-Lafuente","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.biopha.2021.112353_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnano.2020.589832","article-title":"Nanotechnology-based approaches for the detection of SARS-CoV-2","volume":"2","author":"Gupta","year":"2020","journal-title":"Front. Nanotechnol."},{"key":"10.1016\/j.biopha.2021.112353_bib47","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fmicb.2019.01462","article-title":"Application of aptamers in virus detection and antiviral therapy","volume":"10","author":"Zou","year":"2019","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112353_bib48","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1021\/acsnano.0c02439","article-title":"Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection","volume":"14","author":"Qiu","year":"2020","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2021.112353_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112437","article-title":"Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19","volume":"166","author":"Zhu","year":"2020","journal-title":"Biosens. Bioelectron."},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/v7020751","article-title":"Aptamers in diagnostics and treatment of viral infections","volume":"7","author":"Wandtke","year":"2015","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.biopha.2021.112353_bib51","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1039\/b906788d","article-title":"RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein","volume":"134","author":"Ahn","year":"2009","journal-title":"Analyst"},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jviromet.2005.03.004","article-title":"Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA","volume":"127","author":"He","year":"2005","journal-title":"J. Virol. Methods"},{"issue":"14","key":"10.1016\/j.biopha.2021.112353_bib53","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1021\/acs.analchem.0c01394","article-title":"Discovery of aptamers targeting the receptor-binding domain of the SARS-CoV-2 spike glycoprotein","volume":"92","author":"Song","year":"2020","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib54","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1021\/acsnano.0c02823","article-title":"Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor","volume":"14","author":"Seo","year":"2020","journal-title":"ACS nano"},{"issue":"3","key":"10.1016\/j.biopha.2021.112353_bib55","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/JCM.05943-11","article-title":"Characterization of isolates of Salmonella enterica serovar Stanley, a serovar endemic to Asia and associated with travel","volume":"50","author":"Hendriksen","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"18","key":"10.1016\/j.biopha.2021.112353_bib56","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1039\/c2lc40630f","article-title":"Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics","volume":"12","author":"Foudeh","year":"2012","journal-title":"Lab Chip"},{"issue":"273","key":"10.1016\/j.biopha.2021.112353_bib57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/scitranslmed.aaa0056","article-title":"A smartphone dongle for diagnosis of infectious diseases at the point of care","volume":"7","author":"Laksanasopin","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib58","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1021\/acsbiomaterials.1c00318","article-title":"Nanobased platforms for diagnosis and treatment of COVID-19: from benchtop to bedside","volume":"7","author":"Bidram","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biopha.2021.112353_bib59","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.snb.2016.06.081","article-title":"Gold nanoparticles as efficient sensors in colorimetric detection of toxic metal ions: a review","volume":"238","author":"Priyadarshini","year":"2017","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.biopha.2021.112353_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2019.115754","article-title":"Colorimetric sensor array based on gold nanoparticles: design principles and recent advances","volume":"122","author":"Sun","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2021.112353_bib61","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1021\/acsnano.0c03822","article-title":"Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles","volume":"14","author":"Moitra","year":"2020","journal-title":"ACS nano"},{"issue":"8","key":"10.1016\/j.biopha.2021.112353_bib62","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/pathogens10081048","article-title":"Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19","volume":"10","author":"Arora","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.biopha.2021.112353_bib63","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1148\/radiol.2020200905","article-title":"Artificial intelligence distinguishes COVID-19 from community acquired pneumonia on chest CT","volume":"296","author":"Li","year":"2020","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.biopha.2021.112353_bib64","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41591-020-0931-3","article-title":"Artificial intelligence\u2013enabled rapid diagnosis of patients with COVID-19","volume":"26","author":"Mei","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","article-title":"Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography","volume":"10","author":"Rakita","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2021.112353_bib66","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.eng.2020.04.010","article-title":"A deep learning system to screen novel coronavirus disease 2019 pneumonia","volume":"6","author":"Xu","year":"2020","journal-title":"Engineering"},{"issue":"5","key":"10.1016\/j.biopha.2021.112353_bib67","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5152\/dir.2019.20294","article-title":"A review on the use of artificial intelligence for medical imaging of the lungs of patients with coronavirus disease 2019","volume":"26","author":"Ito","year":"2020","journal-title":"Diagn. Interv. Radiol."},{"key":"10.1016\/j.biopha.2021.112353_bib68","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00264-020-04609-7","article-title":"Deep learning COVID-19 detection bias: accuracy through artificial intelligence","volume":"44","author":"Vaid","year":"2020","journal-title":"Int. Orthop."},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib69","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1148\/radiol.2020200343","article-title":"Chest CT for typical coronavirus disease 2019 (COVID-19) pneumonia: relationship to negative RT-PCR testing","volume":"296","author":"Xie","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.biopha.2021.112353_bib70","article-title":"Rapid ai development cycle for the coronavirus (COVID-19) pandemic: initial results for automated detection & patient monitoring using deep learning ct image analysis","author":"Gozes","year":"2020","journal-title":"arXiv Prepr. arXiv:2003. 05037"},{"key":"10.1016\/j.biopha.2021.112353_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.103792","article-title":"Automated detection of COVID-19 cases using deep neural networks with X-ray images","volume":"121","author":"Ozturk","year":"2020","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib72","article-title":"CRISPR-based COVID-19 surveillance using a genomically-comprehensive machine learning approach","author":"Metsky","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.biopha.2021.112353_bib73","article-title":"How artificial intelligence may help the Covid\u201019 pandemic: pitfalls and lessons for the future","author":"Malik","year":"2020","journal-title":"Rev. Med. Virol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112353_bib74","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3390\/nano11071841","article-title":"Nanotechnology integration for SARS-CoV-2 diagnosis and treatment: an approach to preventing pandemic","volume":"11","author":"Asdaq","year":"2021","journal-title":"Nanomaterials"},{"issue":"18","key":"10.1016\/j.biopha.2021.112353_bib75","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2021.112353_bib76","first-page":"1","article-title":"CRISPR\/Cas-new molecular scissors in diagnostics and therapeutics of COVID-19","author":"Gadwal","year":"2021","journal-title":"Indian J. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib77","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1021\/acssensors.0c02312","article-title":"CRISPR systems for COVID-19 diagnosis","volume":"6","author":"Rahimi","year":"2021","journal-title":"ACS Sens."},{"key":"10.1016\/j.biopha.2021.112353_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113012","article-title":"CRISPR-based detection of SARS-CoV-2: a review from sample to result","volume":"178","author":"Nouri","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.biopha.2021.112353_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103036","article-title":"A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection","volume":"61","author":"Huang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2021.112353_bib80","article-title":"An ultrasensitive, rapid, and portable coronavirus SARS-CoV-2 sequence detection method based on CRISPR-Cas12","author":"Lucia","year":"2020","journal-title":"BioRxiv"},{"issue":"17","key":"10.1016\/j.biopha.2021.112353_bib81","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.scib.2020.04.041","article-title":"Rapid and sensitive detection of COVID-19 using CRISPR\/Cas12a-based detection with naked eye readout, CRISPR\/Cas12a-NER","volume":"65","author":"Wang","year":"2020","journal-title":"Sci. Bull."},{"key":"10.1016\/j.biopha.2021.112353_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112316","article-title":"Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis","volume":"164","author":"Huang","year":"2020","journal-title":"Biosens. Bioelectron."},{"issue":"47","key":"10.1016\/j.biopha.2021.112353_bib83","doi-asserted-by":"crossref","first-page":"29518","DOI":"10.1073\/pnas.2010254117","article-title":"Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2","volume":"117","author":"Ramachandran","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2021.112353_bib84","article-title":"All-in-One dual CRISPR-cas12a (AIOD-CRISPR) assay: a case for rapid, ultrasensitive and visual detection of novel coronavirus SARS-CoV-2 and HIV virus","author":"Ding","year":"2020","journal-title":"BioRxiv"},{"issue":"7","key":"10.1016\/j.biopha.2021.112353_bib85","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","article-title":"CRISPR\u2013Cas12-based detection of SARS-CoV-2","volume":"38","author":"Broughton","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2021.112353_bib86","article-title":"CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design","author":"Metsky","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.biopha.2021.112353_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198129","article-title":"iSCAN: an RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2","volume":"288","author":"Ali","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.biopha.2021.112353_bib88","article-title":"A CRISPR-based SARS-CoV-2 diagnostic assay that is robust against viral evolution and RNA editing","author":"Ooi","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2021.112353_bib89","article-title":"Point-of-care testing for COVID-19 using SHERLOCK diagnostics","author":"Joung","year":"2020","journal-title":"MedRxiv"},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0174-y","article-title":"SARS-CoV-2 detection with CRISPR diagnostics","volume":"6","author":"Guo","year":"2020","journal-title":"Cell Discov."},{"issue":"8","key":"10.1016\/j.biopha.2021.112353_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008705","article-title":"Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19","volume":"16","author":"Hou","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2021.112353_bib92","article-title":"A protocol for detection of COVID-19 using CRISPR diagnostics","volume":"8","author":"Zhang","year":"2020"},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib93","doi-asserted-by":"crossref","first-page":"e02402","DOI":"10.1128\/JCM.02402-20","article-title":"A scalable, easy-to-deploy protocol for Cas13-based detection of SARS-CoV-2 genetic material","volume":"59","author":"Rauch","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.biopha.2021.112353_bib94","article-title":"Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2","author":"Arizti-Sanz","year":"2020","journal-title":"bioRxiv"},{"doi-asserted-by":"crossref","unstructured":"K. Yoshimi et al., Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3, 2020.","key":"10.1016\/j.biopha.2021.112353_bib95","DOI":"10.1101\/2020.06.02.20119875"},{"issue":"10","key":"10.1016\/j.biopha.2021.112353_bib96","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/s41596-019-0210-2","article-title":"SHERLOCK: nucleic acid detection with CRISPR nucleases","volume":"14","author":"Kellner","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2021.112353_bib97","article-title":"Rapid, field-deployable nucleobase detection and identification using FnCas9","author":"Azhar","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.biopha.2021.112353_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122591","article-title":"A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): application for the diagnosis of COVID-19","volume":"233","author":"Li","year":"2021","journal-title":"Talanta"},{"issue":"6387","key":"10.1016\/j.biopha.2021.112353_bib99","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaq0179","article-title":"Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6","volume":"360","author":"Gootenberg","year":"2018","journal-title":"Science"},{"issue":"27","key":"10.1016\/j.biopha.2021.112353_bib100","doi-asserted-by":"crossref","first-page":"16711","DOI":"10.1039\/D1RA00644D","article-title":"A review on potential of natural products in the management of COVID-19","volume":"11","author":"Chakravarti","year":"2021","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of responses after SARS-CoV-2 mRNA-1273 vaccination","volume":"384","author":"Widge","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib102","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2\u2014preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib103","first-page":"1","article-title":"Developmental status of the potential vaccines for the mitigation of the COVID-19 pandemic and a focus on the effectiveness of the Pfizer-BioNTech and moderna mRNA vaccines","author":"Noor","year":"2021","journal-title":"Curr. Clin. Microbiol. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib104","first-page":"13426","article-title":"Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine","volume":"13","author":"Waheed","year":"2021","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.biopha.2021.112353_bib105","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/S2213-2600(20)30402-1","article-title":"The Russian vaccine for COVID-19","volume":"8","author":"Burki","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib106","first-page":"1","article-title":"Cost-effectiveness analysis of remdesivir treatment in COVID-19 patients requiring low-flow oxygen therapy: payer perspective in turkey","author":"Oksuz","year":"2021","journal-title":"Adv. Ther."},{"unstructured":"tracker, J.H.U.a.M.C.R.C.C.-c. 2020 [cited 2020 10th March]. \u3008http:\/\/coronavirus.jhu.edu\/map.html\u3009.","key":"10.1016\/j.biopha.2021.112353_bib107"},{"unstructured":"COVID-19. 2021 [cited 2021 3rd October]. \u3008https:\/\/COVID-19.sciensano.be\/sites\/default\/files\/Covid19\/COVID-19_InterimGuidelines_Treatment_ENG.pdf\u3009.","key":"10.1016\/j.biopha.2021.112353_bib108"},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib109","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ageing\/afaa274","article-title":"Efficacy and safety of COVID-19 vaccines in older people","volume":"50","author":"Soiza","year":"2021","journal-title":"Age Ageing"},{"issue":"15","key":"10.1016\/j.biopha.2021.112353_bib110","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.2021.2927","article-title":"The Johnson & Johnson vaccine for COVID-19","volume":"325","author":"Livingston","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2021.112353_bib111","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bmj.n743","article-title":"COVID-19: what do we know about Sputnik V and other Russian vaccines?","volume":"372","author":"Baraniuk","year":"2021","journal-title":"bmj"},{"issue":"6","key":"10.1016\/j.biopha.2021.112353_bib112","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/ptr.6361","article-title":"Safety and toxicity of silymarin, the major constituent of milk thistle extract: an updated review","volume":"33","author":"Soleimani","year":"2019","journal-title":"Phytother. Res."},{"doi-asserted-by":"crossref","unstructured":"N. Mahmood, S. Nasir, K. Hefferon, Plant-Based Drugs and Vaccines for COVID-19. Vaccines, 2021; 9: 15. 2020, s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in \u2026.","key":"10.1016\/j.biopha.2021.112353_bib113","DOI":"10.3390\/vaccines9010015"},{"issue":"8","key":"10.1016\/j.biopha.2021.112353_bib114","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1039\/C9GC00335E","article-title":"Plant molecular farming: production of metallic nanoparticles and therapeutic proteins using green factories","volume":"21","author":"Mohammadinejad","year":"2019","journal-title":"Green Chem."},{"key":"10.1016\/j.biopha.2021.112353_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104277","article-title":"A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19?","volume":"148","author":"Divya","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.biopha.2021.112353_bib116","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1002\/ptr.7097","article-title":"In silico approach of secondary metabolites from Brazilian herbal medicines to search for potential drugs against SARS\u2010CoV\u20102","volume":"35","author":"Amparo","year":"2021","journal-title":"Phytother. Res."},{"issue":"11","key":"10.1016\/j.biopha.2021.112353_bib117","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3390\/molecules25112627","article-title":"Antiviral effects of plant-derived essential oils and their components: an updated review","volume":"25","author":"Ma","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.112353_bib118","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.foodchem.2016.09.203","article-title":"Essential oil composition, total phenolic, flavonoid contents, and antioxidant activity of Thymus species collected from different regions of Iran","volume":"220","author":"Tohidi","year":"2017","journal-title":"Food Chem."},{"issue":"11","key":"10.1016\/j.biopha.2021.112353_bib119","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/biom9110696","article-title":"Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells","volume":"9","author":"Kim","year":"2019","journal-title":"Biomolecules"},{"issue":"26","key":"10.1016\/j.biopha.2021.112353_bib120","doi-asserted-by":"crossref","first-page":"40800","DOI":"10.18632\/oncotarget.8315","article-title":"Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"doi-asserted-by":"crossref","unstructured":"P.K. Mukherjee, Antiviral evaluation of herbal drugs, in: Quality Control and Evaluation of Herbal Drugs, 2019, pp. 599\u2013628.","key":"10.1016\/j.biopha.2021.112353_bib121","DOI":"10.1016\/B978-0-12-813374-3.00016-8"},{"key":"10.1016\/j.biopha.2021.112353_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107618","article-title":"Glycyrrhizin: an alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?","volume":"214","author":"Bailly","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib123","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/v13040609","article-title":"Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease","volume":"13","author":"van de Sand","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib124","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/nu12041193","article-title":"A novel combination of vitamin C, curcumin and glycyrrhizic acid potentially regulates immune and inflammatory response associated with coronavirus infections: a perspective from system biology analysis","volume":"12","author":"Chen","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2021.112353_bib125","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/ced.14357","article-title":"Potential use of turmeric in COVID\u201019","volume":"45","author":"Gupta","year":"2020","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.biopha.2021.112353_bib126","first-page":"829","article-title":"Investigating mechanism of Qing-Fei-Pai-Du-Tang for treatment of COVID-19 by network pharmacology","author":"Zhao","year":"2020","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"10.1016\/j.biopha.2021.112353_bib127","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3389\/fphar.2020.581691","article-title":"Deciphering the pharmacological mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through integrating Network pharmacology and experimental exploration","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.apsb.2020.10.002","article-title":"Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2021.112353_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5324560","article-title":"Alkaloids from Cryptolepis sanguinolenta as potential inhibitors of SARS-CoV-2 viral proteins: an in silico study","volume":"2020","author":"Borquaye","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2021.112353_bib130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.amjms.2021.02.019","article-title":"Novel and evolving therapies for COVID-19 related pulmonary complications","volume":"361","author":"Mehta","year":"2021","journal-title":"Am. J. Med. Sci."},{"issue":"14","key":"10.1016\/j.biopha.2021.112353_bib131","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1021\/acsomega.0c00772","article-title":"Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil","volume":"5","author":"Thuy","year":"2020","journal-title":"ACS Omega"},{"issue":"18","key":"10.1016\/j.biopha.2021.112353_bib132","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.electacta.2011.05.055","article-title":"Electrochemical detection of avian influenza virus H5N1 gene sequence using a DNA aptamer immobilized onto a hybrid nanomaterial-modified electrode","volume":"56","author":"Liu","year":"2011","journal-title":"Electrochim. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2021.112353_bib133","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/2231-4040.101006","article-title":"Influence of nanotechnology on herbal drugs: a review","volume":"3","author":"Ansari","year":"2012","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib134","first-page":"13","article-title":"Comparison and existence of nanotechnology in traditional alternative medicine: an onset to future medicine","volume":"8","author":"Karuppath","year":"2018","journal-title":"Nanosci. Nanotechnol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112353_bib135","article-title":"Recent advances on nanomaterials to COVID\u201019 management: a systematic review on antiviral\/virucidal agents and mechanisms of SARS\u2010CoV\u20102 inhibition\/inactivation","volume":"5","author":"Carvalho","year":"2021","journal-title":"Glob. Chall."},{"issue":"18","key":"10.1016\/j.biopha.2021.112353_bib136","doi-asserted-by":"crossref","first-page":"20995","DOI":"10.1021\/acsami.1c02755","article-title":"Glycyrrhizic acid nanoparticles as antiviral and anti-inflammatory agents for COVID-19 treatment","volume":"13","author":"Zhao","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.biopha.2021.112353_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7454\/psr.v7i3.1082","article-title":"Potential of Jamu in nanotechnology perspective as an alternative treatment for COVID-19","volume":"7","author":"Kurniawan","year":"2020","journal-title":"Pharm. Sci. Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.112353_bib138","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/vaccines9080914","article-title":"Effect of SARS-CoV-2 mutations on the efficacy of antibody therapy and response to vaccines","volume":"9","author":"Yaqinuddin","year":"2021","journal-title":"Vaccines"},{"doi-asserted-by":"crossref","unstructured":"D.-G. Ahn et al., Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19), 2020.","key":"10.1016\/j.biopha.2021.112353_bib139","DOI":"10.4014\/jmb.2003.03011"},{"unstructured":"Public Health Emergency, Pause in the distribution of bamlanivimab, 2021. \u3008https:\/\/www.phe.gov\/emergency\/events\/COVID19\/investigation-MCM\/Bamlanivimab-etesevimab\/Pages\/bamlanivimab-etesevimab-distribution-pause.aspx\u3009.","key":"10.1016\/j.biopha.2021.112353_bib140"},{"unstructured":"FDA. 2021. \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-COVID-19-update-fda-authorizes-monoclonal-antibodies-treatment-COVID-19\u3009.","key":"10.1016\/j.biopha.2021.112353_bib141"},{"unstructured":"Food and Drug Administration, Fact sheet for healthcare providers: emergency use authorization (EUA) of sotrovimab, 2021. Available from: \u3008https:\/\/www.fda.gov\/media\/149534\/download\u3009.","key":"10.1016\/j.biopha.2021.112353_bib142"},{"key":"10.1016\/j.biopha.2021.112353_bib143","article-title":"Can povidone Iodine gargle\/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update","author":"Sivaraman","year":"2021","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"10.1016\/j.biopha.2021.112353_bib144","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.2147\/IJGM.S325861","article-title":"The saliva of probands sucking an Iota-Carrageenan containing Lozenge inhibits viral binding and replication of the most predominant common cold viruses and SARS-CoV-2","volume":"14","author":"Morokutti-Kurz","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib145","article-title":"Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease. A pragmatic multicenter, randomized, double-blind, placebo-controlled trial (CARR-COV-02)","author":"Figueroa","year":"2021","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib146","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2362.1991.tb01383.x","article-title":"Endogenous nitric oxide: physiology, pathology and clinical relevance","volume":"21","author":"Moncada","year":"1991","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.112353_bib147","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jinf.2021.05.009","article-title":"Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection","volume":"83","author":"Winchester","year":"2021","journal-title":"J. Infect."},{"issue":"7869","key":"10.1016\/j.biopha.2021.112353_bib148","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41586-021-03673-2","article-title":"Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants","volume":"595","author":"Ku","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02483-7","article-title":"Cell therapy in patients with COVID-19 using Wharton\u2019s jelly mesenchymal stem cells: a phase 1 clinical trial","volume":"12","author":"Saleh","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib151","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1148\/radiol.2020200330","article-title":"Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion","volume":"295","author":"Huang","year":"2020","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112353_bib152","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12015-020-09973-w","article-title":"Mesenchymal stem cell therapy for COVID-19: present or future","volume":"16","author":"Golchin","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.biopha.2021.112353_bib153","series-title":"Cell Biology and Translational Medicine, Volume 4","first-page":"103","article-title":"Promotion of cell-based therapy: special focus on the cooperation of mesenchymal stem cell therapy and gene therapy for clinical trial studies","author":"Golchin","year":"2018"},{"key":"10.1016\/j.biopha.2021.112353_bib154","first-page":"1","article-title":"Stem cell therapy potency in personalizing severe COVID-19 treatment","author":"Basiri","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40005-017-0370-4","article-title":"Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics","volume":"48","author":"Choi","year":"2018","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.biopha.2021.112353_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06841","article-title":"The role of Nanotechnology in current COVID-19 outbreak","volume":"7","author":"Tavakol","year":"2021","journal-title":"Heliyon"},{"issue":"14","key":"10.1016\/j.biopha.2021.112353_bib157","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2217\/nnm-2021-0004","article-title":"Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation","volume":"16","author":"Singh","year":"2021","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112353_bib158","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijpharm.2018.06.027","article-title":"Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy?","volume":"547","author":"Abo-Zeid","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112353_bib159","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.2147\/IJN.S185806","article-title":"Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection","volume":"13","author":"Hu","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"46","key":"10.1016\/j.biopha.2021.112353_bib160","doi-asserted-by":"crossref","first-page":"42964","DOI":"10.1021\/acsami.9b15032","article-title":"Functional carbon quantum dots as medical countermeasures to human coronavirus","volume":"11","author":"\u0141oczechin","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib161","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.112353_bib162","doi-asserted-by":"crossref","DOI":"10.1088\/2632-959X\/abb714","article-title":"Nanotechnology based approaches for combatting COVID-19 viral infection","volume":"1","author":"Jindal","year":"2020","journal-title":"Nano Express"},{"key":"10.1016\/j.biopha.2021.112353_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101019","article-title":"Insights from nanotechnology in COVID-19 treatment","volume":"36","author":"Tang","year":"2021","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.biopha.2021.112353_bib164","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Thanh Le","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"unstructured":"WHO. 2021. \u3008www.who.int\/publications\/m\/item\/draft-landscape-of-COVID-19\u3009.","key":"10.1016\/j.biopha.2021.112353_bib165"},{"issue":"10","key":"10.1016\/j.biopha.2021.112353_bib166","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1021\/acsnano.0c07197","article-title":"COVID-19 vaccine frontrunners and their nanotechnology design","volume":"14","author":"Chung","year":"2020","journal-title":"ACS nano"},{"issue":"6","key":"10.1016\/j.biopha.2021.112353_bib167","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/erv.12.38","article-title":"Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges","volume":"11","author":"Delrue","year":"2012","journal-title":"Expert Rev. Vaccines"},{"issue":"6","key":"10.1016\/j.biopha.2021.112353_bib168","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib169","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.biopha.2021.112353_bib170","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/17425247.2014.901308","article-title":"Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines","volume":"11","author":"Deering","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"6","key":"10.1016\/j.biopha.2021.112353_bib171","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/156652310793797711","article-title":"Production of non viral DNA vectors","volume":"10","author":"Schleef","year":"2010","journal-title":"Curr. Gene Ther."},{"issue":"9","key":"10.1016\/j.biopha.2021.112353_bib172","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.2021.1375","article-title":"Necessity of 2 doses of the Pfizer and Moderna COVID-19 vaccines","volume":"325","author":"Livingston","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2021.112353_bib173","first-page":"1","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","author":"Vogel","year":"2021","journal-title":"Nature"},{"unstructured":"2021. \u3008https:\/\/www.cdc.gov\/vaccines\/COVID-19\/info-by-product\/moderna\/index.html\u3009.","key":"10.1016\/j.biopha.2021.112353_bib174"},{"unstructured":"2021 [cited 2021 3th April]. \u3008https:\/\/www.cdc.gov\/vaccines\/COVID-19\/info-by-product\/pfizer\/downloads\/storage-summary.pdf\u3009.","key":"10.1016\/j.biopha.2021.112353_bib175"},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib176","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/diagnostics11040579","article-title":"Mini-Review Discussing The Reliability And Efficiency of COVID-19 vaccines","volume":"11","author":"Doroftei","year":"2021","journal-title":"Diagnostics"},{"unstructured":"Calendar, L.C., Communicating About COVID-19 Vaccination.","key":"10.1016\/j.biopha.2021.112353_bib177"},{"issue":"3","key":"10.1016\/j.biopha.2021.112353_bib178","first-page":"1663","article-title":"COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines","volume":"25","author":"Meo","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"27","key":"10.1016\/j.biopha.2021.112353_bib179","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib180","first-page":"6841","article-title":"Reported adverse events following influenza vaccination","volume":"158","author":"van Balveren-Slingerland","year":"2014","journal-title":"Ned. Tijdschr. Geneeskd."},{"unstructured":"W. Zhou, S.S. Ellenberg, Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014. Morbidity and Mortality Weekly Report: MMWR. Surveillance Summaries. Surveillance summaries, 2003.","key":"10.1016\/j.biopha.2021.112353_bib181"},{"unstructured":"Pfizer COVID-19 vaccine EUA fact sheet for healthcare providers administering vaccine 2021 [cited 2021 31th March]. \u3008https:\/\/www.fda.gov\/media\/144413\u3009.","key":"10.1016\/j.biopha.2021.112353_bib182"},{"key":"10.1016\/j.biopha.2021.112353_bib183","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study","volume":"14","author":"El-Shitany","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib184","article-title":"Vaccine designers take first shots at COVID-19","author":"Cohen","year":"2020","journal-title":"Am. Assoc. Adv. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2021.112353_bib185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112353_bib186","first-page":"3","article-title":"Purpuric rash and Thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine","volume":"13","author":"Malayala","year":"2021","journal-title":"Cureus"},{"unstructured":"Moderna COVID-19 Vaccine. Facts Sheets. 2021 [cited 2021 30th April]. \u3008https:\/\/www.idsociety.org\/\u3009 COVID-19-real-time-learning-network\/vaccines\/moderna-COVID-19-vaccine\/.","key":"10.1016\/j.biopha.2021.112353_bib187"},{"key":"10.1016\/j.biopha.2021.112353_bib188","doi-asserted-by":"crossref","first-page":"m3205","DOI":"10.1136\/bmj.m3205","article-title":"COVID-19: Russia approves vaccine without large scale testing or published results","volume":"370","author":"Mahase","year":"2020","journal-title":"BMJ Br. Med. J."},{"key":"10.1016\/j.biopha.2021.112353_bib189","article-title":"COVID-19: Russian vaccine efficacy is 91.6%, show phase III trial results","author":"Mahase","year":"2021","journal-title":"Br. Med. J. Publ. Group"},{"issue":"10275","key":"10.1016\/j.biopha.2021.112353_bib190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3329\/birdem.v11i1.51022","article-title":"Corona vaccine","volume":"11","author":"Uddin","year":"2021","journal-title":"BIRDEM Med. J."},{"unstructured":"2021 [cited 2021 29th April]. \u3008https:\/\/www.news18.com\/news\/india\/russias-sputnik-v-vaccine-approved-for-emergency-use-in-india-all-you-need-to-know-3632546.html\u3009.","key":"10.1016\/j.biopha.2021.112353_bib192"},{"unstructured":"2021 [cited 2021 21th April]. \u3008https:\/\/tass.com\/society\/1274565\u3009.","key":"10.1016\/j.biopha.2021.112353_bib193"},{"key":"10.1016\/j.biopha.2021.112353_bib194","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3389\/fimmu.2020.585354","article-title":"A review of the progress and challenges of developing a vaccine for COVID-19","volume":"11","author":"Sharma","year":"2020","journal-title":"Front. Immunol."},{"unstructured":"2021 [cited 2021 30th April]. \u3008https:\/\/www.globaltimes.cn\/page\/202102\/1215499.shtml\u3009.","key":"10.1016\/j.biopha.2021.112353_bib195"},{"key":"10.1016\/j.biopha.2021.112353_bib196","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ageing\/afaa165","article-title":"Efficacy and safety of COVID-19 vaccines in older people","volume":"49","author":"Soiza","year":"2020","journal-title":"Age Ageing"},{"unstructured":"2021 [cited 2021 22th April]. \u3008https:\/\/www.medicalnewstoday.com\/articles\/johnson-johnson-COVID-19-vaccine-what-are-the-side-effects#How-does-the-vaccine-work\u3009.","key":"10.1016\/j.biopha.2021.112353_bib197"},{"unstructured":"2021 [cited 2021 20th April]. \u3008https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-COVID-19\/janssen-COVID-19-vaccine\u3009.","key":"10.1016\/j.biopha.2021.112353_bib198"},{"unstructured":"[cited 2021 21th April]. \u3008https:\/\/www.precisionvaccinations.com\/vaccines\/epivaccorona-vaccine\u3009.","key":"10.1016\/j.biopha.2021.112353_bib199"},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15789\/2220-7619-ASB-1699","article-title":"A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the \u201cEpiVacCorona\u201d Vaccine for the prevention of COVID-19, in volunteers aged 18\u201360 years (phase I\u2013II)","volume":"11","author":"Ryzhikov","year":"2021","journal-title":"Russ. J. Infect. Immun."},{"doi-asserted-by":"crossref","unstructured":"A. Fernandes et al., COVID-19 vaccine, Endocr. Pract. (2021).","key":"10.1016\/j.biopha.2021.112353_bib201","DOI":"10.1016\/j.eprac.2021.01.013"},{"issue":"26","key":"10.1016\/j.biopha.2021.112353_bib202","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biopha.2021.112353_bib203","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"mRNA vaccines for COVID-19: what, why and how","volume":"17","author":"Park","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.112353_bib204","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat. Med."},{"unstructured":"Vaccines and Related Biological Products Advisory Committee Meeting. [cited 2021, 30th April]. \u3008https:\/\/www.fda.gov\/media\/\u3009.","key":"10.1016\/j.biopha.2021.112353_bib205"},{"unstructured":"2021 [cited 2021 26th April]. \u3008http:\/\/www.nytimes.com\/interactive\/2020\/health\/moderna-COVID-19-vaccine.html\u3009.","key":"10.1016\/j.biopha.2021.112353_bib206"},{"unstructured":"Jonathan Corum, C.Z. 2021 [cited 2021 26th April]. \u3008https:\/\/www.nytimes.com\/interactive\/2020\/health\/novavax-COVID-19-vaccine.html\u3009.","key":"10.1016\/j.biopha.2021.112353_bib207"},{"issue":"3","key":"10.1016\/j.biopha.2021.112353_bib208","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/vaccines8030404","article-title":"COVID-19: mechanisms of vaccination and immunity","volume":"8","author":"Speiser","year":"2020","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.biopha.2021.112353_bib209","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1080\/21645515.2020.1842034","article-title":"Plant-based vaccines and antibodies to combat COVID-19: current status and prospects","volume":"16","author":"Dhama","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"issue":"8","key":"10.1016\/j.biopha.2021.112353_bib210","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/pathogens10081051","article-title":"Potential for developing plant-derived candidate vaccines and biologics against emerging coronavirus infections","volume":"10","author":"Shanmugaraj","year":"2021","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.biopha.2021.112353_bib211","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3390\/ani11071876","article-title":"Intranasal vaccination strategy to control the COVID-19 pandemic from a veterinary medicine perspective","volume":"11","author":"Annas","year":"2021","journal-title":"Animals"},{"issue":"1","key":"10.1016\/j.biopha.2021.112353_bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-94364-5","article-title":"Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice","volume":"11","author":"Rice","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib213","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1021\/acsnano.1c01845","article-title":"Nano-enabled COVID-19 vaccines: meeting the challenges of durable antibody plus cellular immunity and immune escape","volume":"15","author":"Nel","year":"2021","journal-title":"ACS nano"},{"issue":"7","key":"10.1016\/j.biopha.2021.112353_bib214","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1021\/acsnano.0c04006","article-title":"Nanotechnology for COVID-19: therapeutics and vaccine research","volume":"14","author":"Chauhan","year":"2020","journal-title":"ACS nano"},{"issue":"40","key":"10.1016\/j.biopha.2021.112353_bib215","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.vaccine.2011.07.039","article-title":"Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis","volume":"29","author":"Ballester","year":"2011","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.biopha.2021.112353_bib216","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2010.06.121","article-title":"Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen","volume":"28","author":"Sl\u00fctter","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2021.112353_bib217","first-page":"1","article-title":"COVID-19 vaccine hesitancy\u2013reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic","author":"Dhama","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.biopha.2021.112353_bib218","doi-asserted-by":"crossref","DOI":"10.2196\/26874","article-title":"COVID-19 vaccine hesitancy in Canada: content analysis of tweets using the theoretical domains framework","volume":"23","author":"Griffith","year":"2021","journal-title":"J. Med. Internet Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.112353_bib219","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/vaccines9050433","article-title":"An updated review of SARS-CoV-2 vaccines and the importance of effective vaccination programs in pandemic times","volume":"9","author":"Garc\u00eda-Montero","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2021.112353_bib220","doi-asserted-by":"crossref","first-page":"m3846","DOI":"10.1136\/bmj.m3846","article-title":"COVID-19: vaccine roll out could take a year and will require difficult prioritisation decisions","author":"Mahase","year":"2020","journal-title":"Br. Med. J. Publ. Group"},{"doi-asserted-by":"crossref","unstructured":"K. Sharun, K. Dhama, COVID-19 vaccine diplomacy and equitable access to vaccines amid ongoing pandemic, Arch. Med. Res. (2021).","key":"10.1016\/j.biopha.2021.112353_bib221","DOI":"10.1093\/jtm\/taab064"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:48:23Z","timestamp":1760100503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221011379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":221,"alternative-id":["S0753332221011379"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112353","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review on efficient approaches for combating coronaviruses","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112353"}}